Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J C Venter

Showing results (1-10 of 159) with videos related to

Pageof 16
Sort By:
Novartis Foundation Symposium|November 21, 2000
Genomic impact on pharmaceutical developmentJ C Venter
The Journal of Biological Chemistry|April 25, 1983
Muscarinic cholinergic receptor structure. Receptor size, membrane orientation, and absence of major phylogenetic structural diversityJ C Venter
Functional & Integrative Genomics|January 22, 2002
Remarks at the human genome announcementJ C Venter
Survey of Immunologic Research|January 1, 1983
Monoclonal and anti-idiotypic antibodies and the elucidation of receptor structureJ C Venter
Science (New York, N.Y.)|March 1, 1996
Response: more haemophilus and Mycoplasma genesJ C Venter
Molecular Pharmacology|July 1, 1978
Cardiac sites of catecholamine action: diffusion models for soluble and immobilized catecholamine action on isolated cat papillary musclesJ C Venter
Novartis Foundation Symposium|November 21, 2000
From genome to therapy: integrating new technologies with drug development. IntroductionJ C Venter
The Journal of Pharmacy and Pharmacology|April 1, 1993
Identification of new human receptor and transporter genes by high throughput cDNA (EST) sequencingJ C Venter
Journal of Molecular and Cellular Cardiology|December 1, 1982
Monoclonal antibodies and autoantibodies in the isolation and characterization of neurotransmitter receptors: the future of receptor researchJ C Venter
Pharmacological Reviews|June 1, 1982
Immobilized and insolubilized drugs, hormones, and neurotransmitters: properties, mechanisms of action and applicationsJ C Venter
Pageof 16

Showing results (1-10 of 159) with videos related to

Sort By:
Pageof 16
Novartis Foundation Symposium|November 21, 2000
Genomic impact on pharmaceutical developmentJ C Venter
The Journal of Biological Chemistry|April 25, 1983
Muscarinic cholinergic receptor structure. Receptor size, membrane orientation, and absence of major phylogenetic structural diversityJ C Venter
Functional & Integrative Genomics|January 22, 2002
Remarks at the human genome announcementJ C Venter
Survey of Immunologic Research|January 1, 1983
Monoclonal and anti-idiotypic antibodies and the elucidation of receptor structureJ C Venter
Science (New York, N.Y.)|March 1, 1996
Response: more haemophilus and Mycoplasma genesJ C Venter
Molecular Pharmacology|July 1, 1978
Cardiac sites of catecholamine action: diffusion models for soluble and immobilized catecholamine action on isolated cat papillary musclesJ C Venter
Novartis Foundation Symposium|November 21, 2000
From genome to therapy: integrating new technologies with drug development. IntroductionJ C Venter
The Journal of Pharmacy and Pharmacology|April 1, 1993
Identification of new human receptor and transporter genes by high throughput cDNA (EST) sequencingJ C Venter
Journal of Molecular and Cellular Cardiology|December 1, 1982
Monoclonal antibodies and autoantibodies in the isolation and characterization of neurotransmitter receptors: the future of receptor researchJ C Venter
Pharmacological Reviews|June 1, 1982
Immobilized and insolubilized drugs, hormones, and neurotransmitters: properties, mechanisms of action and applicationsJ C Venter
Pageof 16